2022 American Transplant Congress
Immunogenicity of a 3rd Dose of Mrna Covid-19 Vaccine in Kidney Transplant Recipients Who Failed to Respond to 2 Prior Doses
*Purpose: Kidney transplant recipients (KTRs) have diminished immune response and protection after 2-dose mRNA COVID-19 vaccination. It is unknown if additional doses improve neutralization of…2022 American Transplant Congress
Early Outcomes of Kidney Transplant Recipients from Donors with Severe Sars-cov-2 Pneumonia
Baylor University Medical Center, Dallas, TX
*Purpose: Transplantation of kidneys from donors with active SARS-CoV-2 infection is uncommon due to concerns about the risk of viral transmission and kidney quality. To…2022 American Transplant Congress
Lung Transplant Recipients with Sars-cov2 Infection and Bnt162b2 Vaccination Induce Circulating Exosomes with Spike Protein S2 Capable of Inducing Immune Responses to Sars0-cov2 in Mice
1St. Joseph’s Hospital and Medical Center, Phoenix, AZ, 2Yale School of Medicine, New Haven, CT
*Purpose: Exosomes are small vesicles which are released by cells into body fluids. We have demonstrated the presence of circulating exosomes with viral antigens in…2022 American Transplant Congress
Impaired Humoral Response to Second Dose of BNT162b2 Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients in Japan: Prospective Observational Study
1Sapporo City General Hospital, Sapporo, Japan, 2Sapporo Hokuyu Hospital, Sapporo, Japan
*Purpose: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has a major impact on solid organ transplant (SOT) recipients, with mortality rate up to 22%. The…2022 American Transplant Congress
Prognostic Factors for Mortality of COVID-19 Infection in Kidney Transplant Recipients in Thailand: A Nationwide Study
*Purpose: To investigate the mortality risk factors of COVID-19 infection among kidney transplant recipients (KTRs) in Thailand due to data scarcity in Asian populations.*Methods: We…2022 American Transplant Congress
Bacterial Infections After Kidney Transplant Before and After the COVID-19 Pandemic
*Purpose: Infectious complications are a major cause of mortality and morbidity after kidney transplantation. During the COVID-19 pandemia there were several changes in the management…2022 American Transplant Congress
Survey of Current Transplant Center Practices Regarding Covid-19 Vaccine Mandates in the United States
*Purpose: We surveyed current policies of transplant centers regarding a COVID-19 vaccine mandate, and rationales for or against a mandate policy.*Methods: An electronic survey was…2022 American Transplant Congress
Covid-related Neonatal Cholestasis?: Liver Transplantation In Three Infants With Intrauterine Or Perinatal Covid Exposure
1Baylor College of Medicine, Houston, TX, 2Baylor College of Medicine, Houston, TX
*Purpose: The COVID pandemic presents a unique set of challenges during pregnancy including thromboembolic complications, direct placental infection, transplacental transmission, and systemic hyperinflammatory state. The…2022 American Transplant Congress
COVID Infection Among Kidney Transplant Recipient During the Era of COVID Vaccination: Management Outcomes
Nephrology, Medical University of South Carolina, Charleston, SC
*Purpose: COVID pandemic has posed a significant challenge among kidney transplant recipients (KTR) due to their immunocompromised state. There is uncertainty on immunosuppression (IS) management…2022 American Transplant Congress
Attitudes Regarding COVID-19 Vaccine and Vaccine Hesitancy in an Inner-City Kidney Transplant Recipients (KTRs)
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: KTRs comprise a high-risk group for COVID-19 infection due to comorbidities and immunosuppression. Studying how vaccination hesitancy in inner-city KTRs has changed since the…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 20
- Next Page »